Abhinav Jain

Direktor/Vorstandsmitglied bei AYTU BIOPHARMA, INC.

Vermögen: 127 885 $ am 31.05.2026

35 Jahre

63 Beziehungen

Health Technology

Finance

Consumer Services

Profil

Abhinav Jain is currently an Independent Director at Aytu Biopharma, Inc. since 2023, a Director at Xtant Medical Holdings, Inc. starting in 2025, an Independent Director at Eagle Pharmaceuticals, Inc. starting in 2025, and an Independent Director at Talphera, Inc. starting in 2024.
Formerly, Mr. Jain worked as an Associate at Angelo, Gordon & Co. LP.
from 2015 to 2017.
Education includes an undergraduate degree from Massachusetts Institute of Technology in 2012 and an MBA from The Wharton School of the University of Pennsylvania in 2019.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
XTANT MEDICAL HOLDINGS, INC. 0,11 %	15.11.2025	158 228 ( 0,11 % )	73 101 $	31.05.2026
AYTU BIOPHARMA, INC. 0,18 %	13.10.2025	19 500 ( 0,18 % )	44 655 $	31.05.2026
TALPHERA, INC. 0,02 %	22.06.2026	12 412 ( 0,02 % )	10 128 $	31.05.2026

Aktive Positionen von Abhinav Jain

Unternehmen	Position	Beginn
AYTU BIOPHARMA, INC.	Direktor/Vorstandsmitglied	12.06.2023
TALPHERA, INC.	Direktor/Vorstandsmitglied	22.01.2024
XTANT MEDICAL HOLDINGS, INC.	Direktor/Vorstandsmitglied	01.08.2025
EAGLE PHARMACEUTICALS, INC.	Direktor/Vorstandsmitglied	28.08.2025

Alle aktiven Positionen von Abhinav Jain

Ehemalige bekannte Positionen von Abhinav Jain

Unternehmen	Position	Ende
Angelo, Gordon & Co. LP Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities.	Corporate Officer/Principal	01.01.2017

Sehen Sie sich die Erfahrung von Abhinav Jain im Detail an

Ausbildung von Abhinav Jain

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Abhinav Jain im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Angelo, Gordon & Co. LP Angelo, Gordon & Co. LP Investment ManagersFinance TPG Angelo Gordon seeks alternative investment opportunities that will deliver consistent absolute returns for their clients. The firm manages capital across their Credit and Real Estate strategies, all of which employ a disciplined investment philosophy that combines fundamental in-depth research with a diversification strategy 20 designed to reduce downside risk. The research team is the cornerstone of all investment activities.	Finance
Eagle Pharmaceuticals, Inc. Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology	Health Technology
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Talphera, Inc. Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products	Health Technology
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aytu Biopharma, Inc. Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Xtant Medical Holdings, Inc. Xtant Medical Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and commercializes surgical products	Health Technology